Traumatic Brain Injury, Part II

Section 6 Clinical Sequelae and Long-Term Outcome 29. Predicting Outcome after Traumatic Brain Injury 30. Movement disorders secondary to craniocerebral trauma 31. Language impairments in traumatic brain injury: a window into complex cognitive performance 32. Connecting clinical and experimental investigations of awareness in traumatic brain injury 33. Post-Traumatic Epilepsy 34. Autonomic Dysfunction Syndromes after Acute Brain Injury 35. Sleep in traumatic brain injury 36. Post traumatic headaches 37. Traumatic brain injury and cognition 38. Mood disorders 39. Post-traumatic stress disorder and traumatic brain injury 40. Long term functional outcomes and psychosocial consequences of traumatic brain injury 41. Sequelae in Children: Developmental ConsequencesSection 7 Brain Plasticity and Long-Term Risks 42. Cellular and Molecular Neuronal Plasticity 43. Traumatic brain injury and reserve 44. Traumatic brain injury and late-life dementia45. Genetic factors in traumatic brain injurySection 8 Conducting Clinical Trials in Traumatic Brain Injury 46. Ethical and Regulatory Considerations in the Design of Traumatic Brain Injury Clinical Studies 47. Design of Acute Neuroprotection Studies 48. Design of brain injury rehabilitation treatment research 49. The ebb and flow of traumatic brain injury research

Dr. Grafman has been the director of Brain Injury Research at the Shirley Ryan AbilityLab ((SRALab)formally known as the Rehabilitation Institute of Chicago) since 2012 and is on faculty at Northwestern University's Feinberg School of Medicine in the Departments of Physical Medicine and Rehabilitation, Neurology, Psychiatry and Behavioral Sciences, and the Cognitive Neurology and Alzheimer's Disease Center as well as the Department of Psychology in the Weinberg College of Arts and Sciences. Before joining the SRALab, Dr. Grafman was briefly director of Traumatic Brain Injury Research at the Kessler Foundation in West Orange New Jersey. Prior to that appointment in 2011, Dr. Grafman was Chief of the Cognitive Neuroscience Section at the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland for many years. His investigation of brain function and behavior contributes to advances in medicine, rehabilitation, and psychology, and informs ethics, law, philosophy,and health policy. His study of the human prefrontal cortex and cognitive neuroplasticity incorporates neuroimaging and genetics, an approach that is expanding our knowledge of the functions of the human frontal lobes, as well as the effects of neurological disorders that impair frontal lobe brain function.